Liquidata Share/ETF/Trust Analysis
Portfolio Holdings Detail for ISIN IE00BDZVHG35
| Stock Name / Fund | iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) |
| Issuer | Blackrock |
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
| ETF Ticker | BTEE(USD) LSE |
| ETF Ticker | BTEE.L(GBP) LSE |
Holdings detail for TRDA
| Stock Name | Entrada Therapeutics Inc |
| Ticker | TRDA(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US29384C1080 |
Show aggregate TRDA holdings
News associated with TRDA
- Entrada Therapeutics, Inc. (NASDAQ:TRDA) Receives $25.67 Average Price Target from Brokerages
- Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) has received an average recommendation of “Buy” from the five brokerages that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation, three have given a buy recommendation and one has given a strong buy recommendation to the company. The […] - 2025-09-12 02:01:10
- Insider Selling: Entrada Therapeutics, Inc. (NASDAQ:TRDA) Major Shareholder Sells 6,935 Shares of Stock
- Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) major shareholder Ventures V. L.P. 5Am sold 6,935 shares of the firm’s stock in a transaction dated Wednesday, July 9th. The stock was sold at an average price of $7.50, for a total value of $52,012.50. Following the sale, the insider directly owned 1,093,313 shares of the […] - 2025-07-14 06:12:51
- Insider Selling: Entrada Therapeutics, Inc. (NASDAQ:TRDA) Major Shareholder Sells 20,065 Shares of Stock
- Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) major shareholder Ventures V. L.P. 5Am sold 20,065 shares of the stock in a transaction dated Wednesday, July 9th. The shares were sold at an average price of $7.50, for a total value of $150,487.50. Following the completion of the transaction, the insider owned 3,163,066 shares of […] - 2025-07-14 05:38:49
- Entrada Therapeutics, Inc. (NASDAQ:TRDA) Director Sells $202,500.00 in Stock
- Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) Director Kush Parmar sold 27,000 shares of the stock in a transaction that occurred on Wednesday, July 9th. The stock was sold at an average price of $7.50, for a total transaction of $202,500.00. Following the sale, the director owned 1,093,313 shares in the company, valued at […] - 2025-07-14 05:38:48
- Entrada Therapeutics (NASDAQ:TRDA) Shares Down 3.6% – Should You Sell?
- Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) fell 3.6% during mid-day trading on Monday . The company traded as low as $6.87 and last traded at $6.97. 149,403 shares traded hands during trading, an increase of 11% from the average session volume of 134,750 shares. The stock had previously closed at $7.23. […] - 2025-07-08 04:35:07
- UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 21,594 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA)
- UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) by 152.5% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 35,750 shares of the company’s stock after acquiring an additional 21,594 shares during […] - 2025-06-12 05:12:44
- First Trust Advisors LP Cuts Position in Entrada Therapeutics, Inc. (NASDAQ:TRDA)
- First Trust Advisors LP decreased its position in shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) by 9.6% during the fourth quarter, HoldingsChannel reports. The firm owned 73,749 shares of the company’s stock after selling 7,800 shares during the period. First Trust Advisors LP’s holdings in Entrada Therapeutics were worth $1,275,000 at the end […] - 2025-05-08 05:54:57
- Barclays PLC Has $887,000 Holdings in Entrada Therapeutics, Inc. (NASDAQ:TRDA)
- Barclays PLC grew its stake in Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) by 13.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 51,365 shares of the company’s stock after purchasing an additional 6,255 shares during the period. Barclays PLC’s holdings in […] - 2025-05-06 04:40:49
- Geode Capital Management LLC Cuts Stock Position in Entrada Therapeutics, Inc. (NASDAQ:TRDA)
- Geode Capital Management LLC trimmed its stake in shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) by 0.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 573,891 shares of the company’s stock after selling 2,560 shares during […] - 2025-04-23 05:06:55
- Entrada Therapeutics, Inc. (NASDAQ:TRDA) Stock Holdings Increased by Federated Hermes Inc.
- Federated Hermes Inc. boosted its stake in shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) by 3,104.3% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 99,814 shares of the company’s stock after purchasing an additional 96,699 shares during the period. Federated Hermes Inc. owned about […] - 2025-04-15 04:54:50
- Arrowstreet Capital Limited Partnership Has $3.85 Million Stock Position in Entrada Therapeutics, Inc. (NASDAQ:TRDA)
- Arrowstreet Capital Limited Partnership increased its stake in shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) by 123.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 222,520 shares of the company’s stock after acquiring an additional 122,823 shares during the quarter. Arrowstreet Capital […] - 2025-04-09 05:30:53
- AlphaQuest LLC Invests $70,000 in Entrada Therapeutics, Inc. (NASDAQ:TRDA)
- AlphaQuest LLC purchased a new position in Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) in the fourth quarter, Holdings Channel reports. The institutional investor purchased 4,046 shares of the company’s stock, valued at approximately $70,000. A number of other large investors have also recently made changes to their positions in TRDA. Janus Henderson Group PLC […] - 2025-03-20 06:12:50
- Entrada Therapeutics (NASDAQ:TRDA) Receives Buy Rating from HC Wainwright
- Entrada Therapeutics (NASDAQ:TRDA – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a note issued to investors on Tuesday,Benzinga reports. They currently have a $20.00 price objective on the stock. HC Wainwright’s price target suggests a potential upside of 66.39% from the company’s previous close. TRDA has been […] - 2025-02-27 06:44:55
- China Universal Asset Management Co. Ltd. Makes New Investment in Entrada Therapeutics, Inc. (NASDAQ:TRDA)
- China Universal Asset Management Co. Ltd. bought a new position in shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 7,931 shares of the company’s stock, valued at approximately $137,000. A number of other […] - 2025-02-04 07:03:05
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) TRDA holdings
| Date | Number of TRDA Shares Held | Base Market Value of TRDA Shares | Local Market Value of TRDA Shares | Change in TRDA Shares Held | Change in TRDA Base Value | Current Price per TRDA Share Held | Previous Price per TRDA Share Held |
|---|
| 2025-11-11 (Tuesday) | 26,307 | USD 202,564 | USD 202,564 | 0 | USD 11,575 | USD 7.7 | USD 7.26001 |
| 2025-11-10 (Monday) | 26,307 | USD 190,989 | USD 190,989 | 69 | USD 9,684 | USD 7.26001 | USD 6.91002 |
| 2025-11-07 (Friday) | 26,238 | USD 181,305 | USD 181,305 | 0 | USD -1,049 | USD 6.91002 | USD 6.95 |
| 2025-11-06 (Thursday) | 26,238 | USD 182,354 | USD 182,354 | 69 | USD 741 | USD 6.95 | USD 6.94001 |
| 2025-11-05 (Wednesday) | 26,169 | USD 181,613 | USD 181,613 | 0 | USD 8,374 | USD 6.94001 | USD 6.62001 |
| 2025-11-04 (Tuesday) | 26,169 | USD 173,239 | USD 173,239 | 70 | USD -3,712 | USD 6.62001 | USD 6.77999 |
| 2025-11-03 (Monday) | 26,099 | USD 176,951 | USD 176,951 | 0 | USD -4,437 | USD 6.77999 | USD 6.95 |
| 2025-10-31 (Friday) | 26,099 | USD 181,388 | USD 181,388 | 0 | USD 1,305 | USD 6.95 | USD 6.9 |
| 2025-10-30 (Thursday) | 26,099 | USD 180,083 | USD 180,083 | 350 | USD 2,672 | USD 6.9 | USD 6.89002 |
| 2025-10-29 (Wednesday) | 25,749 | USD 177,411 | USD 177,411 | 140 | USD -10,815 | USD 6.89002 | USD 7.34999 |
| 2025-10-28 (Tuesday) | 25,609 | USD 188,226 | USD 188,226 | 0 | USD 1,024 | USD 7.34999 | USD 7.31001 |
| 2025-10-27 (Monday) | 25,609 | USD 187,202 | USD 187,202 | 0 | USD 12,293 | USD 7.31001 | USD 6.82998 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of TRDA by Blackrock for IE00BDZVHG35
Show aggregate share trades of TRDA| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-11-10 | BUY | 69 | | | 7.260* | | 8.83 |
| 2025-11-06 | BUY | 69 | | | 6.950* | | 8.86 |
| 2025-11-04 | BUY | 70 | | | 6.620* | | 8.89 |
| 2025-10-30 | BUY | 350 | 7.020 | 6.600 | 6.642 | USD 2,325 | 8.93 |
| 2025-10-29 | BUY | 140 | 6.890 | 7.410 | 7.358 | USD 1,030 | 8.94 |
| 2025-10-22 | SELL | -276 | 6.310 | 6.490 | 6.472 | USD -1,786 | 9.02 Profit of 703 on sale |
| 2025-10-20 | BUY | 138 | 6.250 | 6.330 | 6.322 | USD 872 | 9.06 |
| 2025-10-17 | BUY | 344 | 5.870 | 6.245 | 6.207 | USD 2,135 | 9.08 |
| 2025-10-15 | BUY | 544 | 6.190 | 6.260 | 6.253 | USD 3,402 | 9.10 |
| 2025-10-03 | BUY | 490 | 6.000 | 6.140 | 6.126 | USD 3,002 | 9.15 |
| 2025-10-02 | BUY | 70 | 5.920 | 6.058 | 6.044 | USD 423 | 9.18 |
| 2025-09-30 | BUY | 140 | 5.800 | 5.840 | 5.836 | USD 817 | 9.23 |
| 2025-09-26 | BUY | 140 | 5.800 | 5.918 | 5.906 | USD 827 | 9.28 |
| 2025-09-25 | BUY | 140 | 5.580 | 5.640 | 5.634 | USD 789 | 9.31 |
| 2025-09-18 | BUY | 70 | 5.550 | 5.755 | 5.735 | USD 401 | 9.34 |
| 2025-09-17 | BUY | 210 | 5.090 | 5.505 | 5.464 | USD 1,147 | 9.38 |
| 2025-07-17 | SELL | -138 | 6.380 | 6.625 | 6.601 | USD -911 | 9.49 Profit of 399 on sale |
| 2025-07-11 | SELL | -560 | 6.550 | 6.840 | 6.811 | USD -3,814 | 9.59 Profit of 1,557 on sale |
| 2025-07-02 | BUY | 3,850 | 7.270 | 7.410 | 7.396 | USD 28,475 | 9.68 |
| 2025-06-25 | BUY | 138 | 7.060 | 7.190 | 7.177 | USD 990 | 9.78 |
| 2025-06-11 | BUY | 140 | 7.900 | 8.475 | 8.418 | USD 1,178 | 10.03 |
| 2025-06-10 | BUY | 140 | 8.260 | 8.490 | 8.467 | USD 1,185 | 10.05 |
| 2025-06-04 | SELL | -70 | 7.930 | 8.500 | 8.443 | USD -591 | 10.13 Profit of 118 on sale |
| 2025-04-23 | BUY | 69 | 8.710 | 9.230 | 9.178 | USD 633 | 10.98 |
| 2025-04-10 | SELL | -552 | 7.850 | 8.240 | 8.201 | USD -4,527 | 11.48 Profit of 1,808 on sale |
| 2025-04-08 | SELL | -69 | 7.550 | 8.720 | 8.603 | USD -594 | 11.61 Profit of 208 on sale |
| 2025-04-07 | SELL | -69 | 8.190 | 8.600 | 8.559 | USD -591 | 11.68 Profit of 215 on sale |
| 2025-04-04 | SELL | -350 | 7.940 | 7.990 | 7.985 | USD -2,795 | 11.76 Profit of 1,320 on sale |
| 2025-04-01 | BUY | 2,767 | 8.760 | 9.440 | 9.372 | USD 25,932 | 11.88 |
| 2025-03-31 | SELL | -180 | 9.040 | 9.430 | 9.391 | USD -1,690 | 11.94 Profit of 459 on sale |
| 2025-03-14 | SELL | -960 | 10.810 | 11.140 | 11.107 | USD -10,663 | 12.42 Profit of 1,259 on sale |
| 2025-03-07 | SELL | -120 | 10.770 | 11.040 | 11.013 | USD -1,322 | 12.68 Profit of 200 on sale |
| 2025-03-04 | SELL | -60 | 10.990 | 11.490 | 11.440 | USD -686 | 12.90 Profit of 87 on sale |
| 2025-02-25 | BUY | 120 | 12.120 | 13.170 | 13.065 | USD 1,568 | 13.12 |
| 2025-02-19 | SELL | -60 | 13.000 | 13.219 | 13.197 | USD -792 | 13.14 Loss of -3 on sale |
| 2025-02-13 | BUY | 180 | 12.630 | 12.850 | 12.828 | USD 2,309 | 13.14 |
| 2025-02-12 | BUY | 60 | 12.690 | 13.000 | 12.969 | USD 778 | 13.18 |
| 2025-02-11 | BUY | 240 | 12.240 | 12.910 | 12.843 | USD 3,082 | 13.25 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of TRDA
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 36,824 | 195 | 155,594 | 23.7% |
| 2025-09-18 | 41,246 | 40 | 1,212,893 | 3.4% |
| 2025-09-17 | 58,645 | 0 | 399,878 | 14.7% |
| 2025-09-16 | 12,727 | 0 | 95,025 | 13.4% |
| 2025-09-15 | 35,285 | 0 | 104,907 | 33.6% |
| 2025-09-12 | 58,183 | 0 | 119,131 | 48.8% |
| 2025-09-11 | 17,557 | 0 | 105,409 | 16.7% |
| 2025-09-10 | 14,949 | 0 | 113,645 | 13.2% |
| 2025-09-09 | 23,027 | 0 | 100,655 | 22.9% |
| 2025-09-08 | 12,901 | 76 | 156,067 | 8.3% |
| 2025-09-05 | 21,640 | 0 | 150,704 | 14.4% |
| 2025-09-04 | 27,785 | 0 | 118,420 | 23.5% |
| 2025-09-03 | 18,229 | 0 | 125,684 | 14.5% |
| 2025-09-02 | 16,433 | 2,210 | 90,706 | 18.1% |
| 2025-08-29 | 14,176 | 0 | 61,034 | 23.2% |
| 2025-08-28 | 15,770 | 0 | 38,172 | 41.3% |
| 2025-08-27 | 6,024 | 0 | 27,550 | 21.9% |
| 2025-08-26 | 7,775 | 0 | 50,063 | 15.5% |
| 2025-08-25 | 17,366 | 0 | 55,138 | 31.5% |
| 2025-08-22 | 8,099 | 0 | 52,443 | 15.4% |
| 2025-08-21 | 22,119 | 0 | 54,642 | 40.5% |
| 2025-08-20 | 6,949 | 0 | 66,020 | 10.5% |
| 2025-08-19 | 13,372 | 0 | 76,569 | 17.5% |
| 2025-08-18 | 13,345 | 25 | 63,179 | 21.1% |
| 2025-08-15 | 31,082 | 0 | 72,899 | 42.6% |
| 2025-08-14 | 19,887 | 0 | 65,839 | 30.2% |
| 2025-08-13 | 13,070 | 0 | 60,871 | 21.5% |
| 2025-08-12 | 25,298 | 0 | 69,619 | 36.3% |
| 2025-08-11 | 12,529 | 0 | 70,205 | 17.8% |
| 2025-08-08 | 15,143 | 3,499 | 90,450 | 16.7% |
| 2025-08-07 | 99,266 | 8,617 | 168,002 | 59.1% |
| 2025-08-06 | 60,832 | 7,403 | 270,925 | 22.5% |
| 2025-08-05 | 49,338 | 0 | 165,272 | 29.9% |
| 2025-08-04 | 20,095 | 0 | 117,152 | 17.2% |
| 2025-08-01 | 26,338 | 2,932 | 81,354 | 32.4% |
| 2025-07-31 | 55,071 | 505 | 96,541 | 57.0% |
| 2025-07-30 | 25,483 | 0 | 61,873 | 41.2% |
| 2025-07-29 | 38,833 | 0 | 74,459 | 52.2% |
| 2025-07-28 | 20,413 | 0 | 51,423 | 39.7% |
| 2025-07-25 | 15,060 | 197 | 54,274 | 27.7% |
| 2025-07-24 | 12,100 | 0 | 37,467 | 32.3% |
| 2025-07-23 | 9,645 | 10 | 34,231 | 28.2% |
| 2025-07-22 | 11,506 | 0 | 52,742 | 21.8% |
| 2025-07-21 | 7,438 | 0 | 24,580 | 30.3% |
| 2025-07-18 | 7,706 | 0 | 31,697 | 24.3% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.